Sequential Targeting of CD52 and TNF Allows Early Minimization Therapy in Kidney Transplantation: From a Biomarker to Targeting in a Proof-Of-Concept Trial. by Ondrej Viklicky, Petra Hruba, Stefan Tomiuk, Sabrina Schmitz, Bernhard Gerstmayer, Birgit Sawitzki, Patrick Miqueu, Petra Mrazova, Irena Tycova, Eva Svobodova, Eva Honsova, Uwe Janssen, Hans-Dieter Volk, Petra Reinke

Get full text